Seroprevalence of antibodies to SARS-CoV-2 in 10 US sites

0

What The Study Did: This study estimates how common SARS-CoV-2 antibodies are in convenience samples from 10 geographic sites in the United States.

Authors: Fiona P. Havers, M.D., M.H.S., of the CDC COVID-19 Response Team at the Centers for Disease Control and Prevention in Atlanta, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamainternmed.2020.4130)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

###

Media advisory: The full study and editorial are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.4130?guestAccessKey=7a5c32e6-3c27-41b3-b46c-43c4a38bbe00&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072120

Media Contact
JAMA Network Media Relations

[email protected]

Leave A Reply

Your email address will not be published.